Challenges, Opportunities, and Priorities for Advancing Breast Cancer Control in Zambia: A Consultative Meeting on Breast Cancer Control.


Journal

Journal of global oncology
ISSN: 2378-9506
Titre abrégé: J Glob Oncol
Pays: United States
ID NLM: 101674751

Informations de publication

Date de publication:
03 2019
Historique:
entrez: 26 3 2019
pubmed: 26 3 2019
medline: 23 7 2020
Statut: ppublish

Résumé

In 2016, the Zambian government made cancer control a national priority and released a National Cancer Control Strategic Plan for 2016 to 2021, which focuses on malignancies of the breast, cervix, and prostate, and retinoblastoma. The plan calls for a collective reduction in the cancer burden by 50%. In support of this vision, Susan G. Komen sponsored a consultative meeting in Lusaka, Zambia, in September 2017 to bring together the country's main breast cancer stakeholders and identify opportunities to improve breast cancer control. The recommendations generated during the discussions are presented. There was general agreement that the first step toward breast cancer mortality reduction should consist of implementation of early detection service platforms focused on women who are symptomatic. Participants also agreed that the management of all components of the national breast cancer control program should be integrated and led by the Ministry of Health. As much as possible, early detection and treatment services presently offered by the Cervical Cancer Prevention Program of Zambia and Cancer Diseases Hospital should be leveraged. Efforts are under way through multiple stakeholders to implement the following recommendations: development of national guidelines for the early diagnosis of breast cancer, training of breast surgeons, implementation of early detection and surgical treatment service platforms at the district-hospital level, and epidemiologic research, including the improvement of electronic recording mechanisms.

Identifiants

pubmed: 30908146
doi: 10.1200/JGO.18.00222
pmc: PMC6449071
doi:

Types de publication

Consensus Development Conference Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Références

Glob Health Promot. 2013 Dec;20(4 Suppl):57-64
pubmed: 24722743
Lancet Oncol. 2017 Oct;18(10):e607-e617
pubmed: 28971827
J Glob Oncol. 2018 Sep;4:1-8
pubmed: 30241176
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 2018 Apr 15;142(8):1568-1579
pubmed: 29197068
PLoS One. 2018 May 10;13(5):e0196985
pubmed: 29746541
JAMA Oncol. 2016 Aug 1;2(8):994-5
pubmed: 27228333
PLoS One. 2015 Apr 17;10(4):e0122169
pubmed: 25885821

Auteurs

Anna Cabanes (A)

Susan G. Komen, Washington, DC.

Sharon Kapambwe (S)

Ministry of Health, Lusaka, Zambia.

Susan Citonje-Msadabwe (S)

Cancer Diseases Hospital, Lusaka, Zambia.

Groesbeck P Parham (GP)

University of North Carolina, Chapel Hill, NC, and University of Zambia, Lusaka, Zambia.

Kennedy Lishimpi (K)

Cancer Diseases Hospital, Lusaka, Zambia.

Tauane A Cruz (TA)

Susan G. Komen, Dallas, TX.

Surendra Shastri (S)

University of Texas, MD Anderson Cancer Center, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH